Van der Meijden works with the Cardiovascular Research Institute Maastricht (CARIM) and the Thrombosis Expertise Center of the Cardiovascular Center Maastricht in the Netherlands. The award provides recipients with € 50.000 per year for a maximum of two years.
"I am focusing on translational research in the field of thrombosis and hemostasis, bridging cellular aspects (particularly platelets) with clinical aspects and patient care," she said. "My main research interst concerns the interaction mechanisms between platelets and coagulation in a broad area of both thrombosis and hemostasis-related studies."
Van der Meijden explained that she applied for the Fellowship because she hoped to gain new insights into the determinants of bleeding in patients with thrombocytopenia due to hematological malignancies and chemotherapy.
"By developing new animal models and translating the animal work to patient diagnosis and treatment, I am able to acquire expert knowledge on the risk assessment of bleeding and transfusion strategy in acquired thrombocytopenia," she said. "In addition, this fellowship supports me in my pursuit to become an independent researcher within the institute and to further extend my own line of research."